OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Interleukin-6 Signaling in Clinic
Sujin Kang, Toshio Tanaka, Masashi Narazaki, et al.
Immunity (2019) Vol. 50, Iss. 4, pp. 1007-1023
Open Access | Times Cited: 728

Showing 1-25 of 728 citing articles:

Cytokine Storm
David C. Fajgenbaum, Carl H. June
New England Journal of Medicine (2020) Vol. 383, Iss. 23, pp. 2255-2273
Open Access | Times Cited: 2531

Cytokine release syndrome in severe COVID-19
John B. Moore, Carl H. June
Science (2020) Vol. 368, Iss. 6490, pp. 473-474
Closed Access | Times Cited: 1882

Aging in COVID-19: Vulnerability, immunity and intervention
Yiyin Chen, Sabra L. Klein, Brian T. Garibaldi, et al.
Ageing Research Reviews (2020) Vol. 65, pp. 101205-101205
Open Access | Times Cited: 916

IL-6 in inflammation, autoimmunity and cancer
Toshio Hirano
International Immunology (2020) Vol. 33, Iss. 3, pp. 127-148
Open Access | Times Cited: 900

Targeting STAT3 in Cancer Immunotherapy
Sailan Zou, Qiyu Tong, Bowen Liu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 726

Translating IL-6 biology into effective treatments
Ernest Choy, Fabrizio De Benedetti, Tsutomu Takeuchi, et al.
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 6, pp. 335-345
Open Access | Times Cited: 543

The cytokine network involved in the host immune response to periodontitis
Weiyi Pan, Qingxuan Wang, Qianming Chen
International Journal of Oral Science (2019) Vol. 11, Iss. 3
Open Access | Times Cited: 536

The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 508

Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
Yuying Liu, Yiliang Fang, Xinfeng Chen, et al.
Science Immunology (2020) Vol. 5, Iss. 43
Open Access | Times Cited: 441

Side-effect management of chimeric antigen receptor (CAR) T-cell therapy
Maria‐Luisa Schubert, Michael Schmitt, L. Wang, et al.
Annals of Oncology (2020) Vol. 32, Iss. 1, pp. 34-48
Open Access | Times Cited: 361

Interleukin-6: A Masterplayer in the Cytokine Network
Peter Uciechowski, Wolfram C. M. Dempke
Oncology (2020) Vol. 98, Iss. 3, pp. 131-137
Closed Access | Times Cited: 359

Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6
Daniel J. Tyrrell, Daniel R. Goldstein
Nature Reviews Cardiology (2020) Vol. 18, Iss. 1, pp. 58-68
Open Access | Times Cited: 313

Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
Wei Luo, Yixin Li, Lijun Jiang, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 8, pp. 531-543
Open Access | Times Cited: 276

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 275

Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
Lars Fugger, Lise T. Jensen, Jamie Rossjohn
Cell (2020) Vol. 181, Iss. 1, pp. 63-80
Closed Access | Times Cited: 273

Historical overview of the interleukin-6 family cytokine
Sujin Kang, Masashi Narazaki, Hozaifa Metwally, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 5
Open Access | Times Cited: 273

The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Rajendra Karki, Thirumala‐Devi Kanneganti
Trends in Immunology (2021) Vol. 42, Iss. 8, pp. 681-705
Open Access | Times Cited: 272

IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
Sujin Kang, Toshio Tanaka, Hitomi Inoue, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 36, pp. 22351-22356
Open Access | Times Cited: 267

Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 263

Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms
Sujin Kang, Tadamitsu Kishimoto
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 7, pp. 1116-1123
Open Access | Times Cited: 217

Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease
Stefan Schreiber, Konrad Aden, Joana P. Bernardes, et al.
Gastroenterology (2021) Vol. 160, Iss. 7, pp. 2354-2366.e11
Open Access | Times Cited: 192

Inflammation and sarcopenia: A focus on circulating inflammatory cytokines
Linyuan Pan, Wenqing Xie, Xin Fu, et al.
Experimental Gerontology (2021) Vol. 154, pp. 111544-111544
Closed Access | Times Cited: 176

Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
Mansur Aliyu, Fatema Tuz Zohora, Abubakar Umar Anka, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109130-109130
Open Access | Times Cited: 163

STAT proteins in cancer: orchestration of metabolism
Yijia Li, Chunyan Zhang, Antons Martincuks, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 115-134
Closed Access | Times Cited: 154

Page 1 - Next Page

Scroll to top